Test-retest Reliability and Correlations of 5 Global Measures Addressing At-work Productivity Loss in Patients with Rheumatic Diseases
Sarah Leggett(Manchester Academic Health Science Centre), Bruno Fautrel, Jamie C. Sergeant(Manchester Academic Health Science Centre), Catherine Hofstetter(Manchester Academic Health Science Centre), Suzanne Verstappen(Arthritis UK), Dorcas Beaton(University of Toronto), Annelies Boonen(Maastricht University), Denise Linton(Manchester Academic Health Science Centre), Diane Lacaille(Manchester Academic Health Science Centre), Carlo Alberto Scirè(Azienda Ospedaliera San Gerardo), Carina Mihai(Carol Davila University of Medicine and Pharmacy), Ingemar F. Petersson(Manchester Academic Health Science Centre), Antje van der Zee‐Neuen(Manchester Academic Health Science Centre), Sabrina Dadoun(Manchester Academic Health Science Centre), Pam Rogers(Manchester Academic Health Science Centre), Sofia Hagel(Manchester Academic Health Science Centre), Mihai Bojincă(Manchester Academic Health Science Centre)
Cited by 24
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
|The Lancet Rheumatology|2021|292